José Rojas‐SuarezJose F. SantacruzYasaira PajaroFabian MazaBremen De MucioClaudio SosaSuzanne Jacob SerruyaMario Alberto Camiro PérezSandra ContrerasWalter Annicchiarico2026-03-222026-03-22202410.1002/ijgo.15818https://doi.org/10.1002/ijgo.15818https://andeanlibrary.org/handle/123456789/75544The CLAP/NAMO values were comparable to the WHO maternal near-miss criteria, indicating that the WHO standards might not be superior in this population. These findings suggest that maternal near-miss thresholds can be adapted regionally, improving the identification and management of severe maternal complications in Latin America.enMedicineProspective cohort studyCohortPopulationCreatinineLatin AmericansCohort studyPediatricsInternal medicineDevelopment of a new definition of maternal near miss based on organ dysfunction in Latin America and the Caribbean: A prospective multicenter cohort studyarticle